Can Semaglutide Give You Heartburn — and What Can You Do About It?

Heartburn and acid reflux are recognised gastrointestinal side effects of semaglutide, listed in the Wegovy SmPC and on the NHS medicines page for semaglutide.
Slowing of gastric emptying is the main mechanism: food stays in the stomach longer, increasing the chance of acid creeping upward.
Symptoms are typically most noticeable after starting treatment or moving to a higher dose, and often settle within days to a few weeks.
Simple adjustments (smaller meals, avoiding lying down after eating, cutting back on fatty or acidic foods) can reduce discomfort without stopping treatment.

Yes, semaglutide can cause heartburn in some people. Clinical trials for Wegovy recorded indigestion and acid reflux among the gastrointestinal side effects that affect a meaningful proportion of users, particularly in the early weeks of treatment or after a dose increase. These effects stem from how the medicine works rather than any fault in the product itself, and for many people they ease considerably within a few weeks. Because semaglutide is a prescription-only medicine, it requires a clinical assessment before a prescriber decides whether it is right for you — and that same prescriber is your first resource if heartburn becomes a problem once you start.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide produces heartburn, who tends to feel it most, and what actually helps

What the trial data and NHS guidance say about reflux and indigestion on semaglutide

The STEP 1 trial, published in the New England Journal of Medicine, remains the principal piece of evidence behind Wegovy's licence. Across 68 weeks with 2.4 mg semaglutide, gastrointestinal events were the most commonly reported adverse effects in the active group, with nausea, diarrhoea, vomiting and constipation leading the list. Dyspepsia (the clinical term that covers indigestion, bloating and the burning sensation most people call heartburn) featured consistently throughout the programme. The NHS medicines page for semaglutide lists acid reflux, indigestion and burping as common side effects that patients should expect to be told about before they start.

Critically, the trial data show that these effects are not randomly distributed across treatment: they cluster around initiation and each upward dose step. Once someone has been on a given dose for three to four weeks, the gastric system typically adjusts. That pattern matters for managing expectations, the first pen, or the pen at a new strength, is when most people feel it most acutely.

Does semaglutide give you heartburn at every dose? Not necessarily, and if you want a closer look at how often this happens and why, our page on whether semaglutide can cause heartburn goes through the evidence in detail. Some patients sail through the starter phase without any reflux at all; others find it a real nuisance for a few weeks before it fades. Individual variation is significant, and your prescriber can review whether the timing and character of your symptoms fits the expected pattern or points to something that needs closer attention.

Why semaglutide slows gastric emptying, and why that produces acid symptoms

Semaglutide activates GLP-1 receptors, which influence appetite, blood-sugar regulation and, importantly, the rate at which the stomach empties its contents into the small intestine. Slower gastric emptying is part of how the medicine helps with satiety, you feel full for longer because food is genuinely still there. The downside of that delay is mechanical: a fuller stomach for longer raises the pressure against the lower oesophageal sphincter, the valve that is supposed to stop stomach acid travelling upward. When that pressure increases, acid can slip through, producing the familiar burning sensation in the chest or throat.

This is worth understanding because it shapes which practical steps actually help. Reducing the volume of each meal lowers the pressure on that sphincter. Staying upright for at least an hour after eating gives the stomach time to begin emptying before gravity no longer assists. Fatty meals, very acidic foods, coffee and alcohol all relax the sphincter further, so cutting back on those during the adjustment phase tends to make a noticeable difference. You can read a fuller breakdown of this and related digestive effects on our overview of Wegovy side effects.

If heartburn on semaglutide is severe, persists beyond the first few weeks at a stable dose, or is accompanied by difficulty swallowing or unintentional weight loss beyond what treatment is achieving, speak to your prescriber. Those patterns warrant proper clinical review rather than self-management.

Practical steps that reduce heartburn during semaglutide treatment

Most people find that small behavioural changes do the heavy lifting. Eating slowly and stopping before feeling full works with the medicine's satiety effect rather than against it. Spreading meals into smaller, more frequent portions avoids the pressure spikes that trigger reflux. Keeping the head of the bed slightly raised overnight can help those who experience symptoms primarily at night.

Over-the-counter antacids are generally compatible with semaglutide, but because the medicine slows gastric emptying, any oral drug or supplement taken at the same time may also have its absorption altered. Check with your prescriber or pharmacist before adding anything regularly to your routine. On the question of whether to persist through bad heartburn on Wegovy or pause, there is no single right answer, it depends on severity, whether the dose is still climbing, and what else is going on clinically.

One practical note: when your treatment arrives, the pen is dispatched in plain, unbranded packaging by DPD the next working day, and you can track it on your phone. Storing it correctly in the fridge from the moment it arrives keeps the medicine in the condition tested in the trials, which is worth bearing in mind if you are also managing any storage-sensitive medicines for reflux.

For context on the broader cost picture of private semaglutide treatment in the UK, our Wegovy cost page sets out what a transparent private prescription typically covers. And if you want to understand the fuller risk profile before committing to treatment, the Wegovy health risks page covers what the evidence says about serious as well as common adverse effects.

When heartburn on semaglutide needs medical attention rather than self-management

Heartburn is unpleasant; it is rarely dangerous on its own. But there are situations where it stops being a manageable nuisance and becomes a signal to contact your prescriber promptly. Severe pain in the upper abdomen that radiates through to the back, particularly if it does not settle with antacids and comes with vomiting, should not be attributed to ordinary reflux. In January 2026 the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis, while infrequent, is a known risk with GLP-1 medicines, and its presenting symptom is often severe, persistent stomach pain. That is not heartburn, but the two can be confused in the early stages, and if you are trying to work out what is typical, our page on whether Wegovy gives you heartburn explains what the expected pattern looks like, which is why the MHRA's guidance is to seek urgent medical assessment if pain is severe.

Signs of an allergic reaction (swelling of the face, lips or throat, difficulty breathing, or a widespread rash) also warrant immediate medical help rather than waiting to contact a prescriber. If you are uncertain whether what you are experiencing fits the expected side-effect pattern, our clinical support team is available seven days a week, and you can also report unexpected reactions directly via the MHRA's Yellow Card scheme.

If you are considering semaglutide for weight management and want to understand whether it is clinically suitable for your situation, a free consultation with our GPhC-registered prescribers is the right starting point. A real clinician reviews your answers the same day (not a queue, not an automated system) and discusses your full health picture before any prescription is issued.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions